BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//BIOTECanada - ECPv6.6.4.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.biotech.ca
X-WR-CALDESC:Events for BIOTECanada
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Toronto
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20260308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20261101T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260929
DTEND;VALUE=DATE:20261002
DTSTAMP:20260903T140845
CREATED:20260521T135324Z
LAST-MODIFIED:20260521T141721Z
UID:10000522-1790640000-1790899199@www.biotech.ca
SUMMARY:BIOSPAIN 2026
DESCRIPTION:  \nDiscount code available! Please contact Emily.meyers@biotech.ca to obtain. \nBIOSPAIN is the largest biotechnology event organized by a national bioindustry association in Europe and one of the largest in the world by the number of one-to-one meetings (4\,500) and companies participating (1\,065) and one of the most important annual events in the biotechnology / biopharma sector in the South of Europe. The event consists of a biotech and scientific congress with conferences and plenary sessions by international expert speakers\, an investment forum embedded within the program\, a large trade exhibition and an important partnering event organised by ASEBIO in partnership with BIO’s one-on-one partnering™ system (the organisers of BIO Convention) and local partners. The last full in-person edition of Biospain in 2025 drew over 2\,400 delegates and 1\,065 companies and institutions and 140 investors. There were over 35 countries represented in total\, with large delegations from the UK\, France\, Portugal\, the USA\, Switzerland\, Latin America and Canada\, among others\, representing the international participants almost 45% out of the total number of attendees. The trade exhibition area displayed over 300 exhibitors. Plenty of networking opportunities take place during the event and at the evening receptions. Through the partnering session\, more than 4\,500 one-on-one meetings were held\, which makes it the 3rd largest business and technology transfer partnering events in Europe. It is expected that the numbers will go further up for Biospain 2026. One of the key features of BIOSPAIN is its partnering sessions. \nThe Consulate of Canada in Barcelona\, Global Affairs Canada\, Government of Canada\, has partnered once more with the organizers of the event\, ASEBIO\, the Association of Bio-Enterprises in Spain\, to offer the Canadian companies and institutions\, the very best of this international partnering congress and will take part actively in this edition of Biospain 2026. \nATTENDEES TO BIOSPAIN: \nThe main participants to Biospain are from biotech\, pharmaceutical\, life sciences companies in human and animal health\, research centres\, university and hospital representatives\, as well as CRO and CMOs representatives\, life sciences and health clusters and associations’ representatives and investors/ venture capital firm’s partners focused on the life sciences and health industries sectors. \nTRADE COMMISSIONER IN THE MARKET: \nMs. Aurora Polo\, Trade Commissioner at the Consulate of Canada\, responsible for the Life Sciences and Health Industries sector for Spain and Andorra and Lead of the European Life Sciences Multi-Country Sector Team\, will participate actively in the event and will assist the Canadian delegates prior to\, during and after the event for them to make the most of it\, in terms of assisting them with market sector intelligence for the Spanish market\, with their requests to identify potential partners for business/ trade and science and technology opportunities and other types of partnerships and strategic alliances. She will be delighted to have a meeting with you during the event to learn more about your company’s interests and assist you with the Spanish / European market. \nA HALF-DAY SIDE PROGRAM IN BILBAO WITH SITE VISITS ON THURSDAY\, OCTOBER 1ST: \nMs. Polo will organize for the Canadian delegation\, a half-day program of site visits to the life sciences hub in Bilbao on Thursday\, October 1st with local sector partners\, which will include site visits and meetings with some of the key organizations in the sector in the Basque Country region. \nIf you are interested in participating in BIOSPAIN 2026\, please contact and confirm your interest and participation at the event and please indicate whether you will also attend the half-day program in Bilbao\, on Thursday\, October 1st. \nACCOMMODATION IN BILBAO: \nPlease visit Biospain’s website under the “Travel” section\, which provides a wide range of hotel accommodation with special rates for the event’s delegates:  https://biospain.com/accommodation/ \n\n 
URL:https://www.biotech.ca/event/biospain-2026/
LOCATION:Bilbao Exhibition centre
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20261021T080000
DTEND;TZID=America/Toronto:20261021T090000
DTSTAMP:20260903T140845
CREATED:20260819T171155Z
LAST-MODIFIED:20260819T171248Z
UID:10000533-1792569600-1792573200@www.biotech.ca
SUMMARY:BioQuebec - Attaining Data Sovereignty in Canada: A Practical Roadmap for Life Sciences Using Quebec Private Cloud
DESCRIPTION:Life sciences organizations across Canada are under rising pressure to modernize their infrastructure and prove that sensitive R&D\, clinical\, manufacturing\, and patient data stays sovereign. Yet with standard public XaaS platforms (AWS\, Azure\, etc.)\, “Canada regions” don’t automatically guarantee sovereignty: foreign ownership can still expose data to extraterritorial access (notably under the U.S. CLOUD Act)\, and complex sub-processor chains can quietly move telemetry\, support access\, or backups across borders.  At the same time\, Quebec’s Law 25 and Canadian privacy guidance demand demonstrable cross-border risk assessments\, contractual safeguards\, and transparency to individuals.  \nIn this session\, you’ll get a practical\, regulator-aligned roadmap to achieve true data sovereignty in Canada. Learn how Quebec-hosted private cloud environments can deliver residency\, isolation\, and operational control inside Canada\, while getting a walkthrough of the validation\, governance\, and other evidence needed to meet GxP expectations while keeping data private by design.  \nWalk away ready to choose\, build\, and defend a sovereign cloud strategy that satisfies both innovation goals and auditors.  \n**Please note that this webinar will be conducted entirely in English.** \n  \nAbout the Companies   \nInnovX Solutions is a leading consulting group founded in Montreal\, Canada\, in 2019\, with a mission to provide a consulting experience that exceeds all expectations. InnovX improves technical service operations by facilitating seamless solution adaptation\, ensuring that each deployment is fully qualified for its intended use\, and complying with all applicable regulatory standards.  \nLeaseweb Canada supports more than 20\,000 businesses worldwide by offering public and private cloud\, dedicated server\, and colocation services. With over 25 years of experience and operating more than 30 data centers in Europe\, Asia\, Australia\, and North America\, Leaseweb Canada is positioned as a trusted technology partner for Canadian organizations in the life sciences sector.  \nFounded by a pharmacist in 1991\, Vigilance Santé develops drug treatment software and databases for front-line health care professionals. \n\n\n\n\n\n\n\nOur\nspeaker\n\n\n\n\n\n\n\n\n\n\nFrédéric Landry\nCo-founder of InnovX Solutions\n\n\nFrederic Landry is the co-founder of InnovX Solutions\, a Montreal-based consulting firm dedicated to ensuring the effective and compliant use of technology in regulated industries. Known as a creative thinker with a passion for innovation\, Frederic brings deep expertise in process management and technology governance. With multiple startup ventures and over 20 years of experience in product development\, IT management\, and operations\, he specializes in translating complex\, fast-moving technologies—like cloud and AI—into practical\, audit-ready strategies that work in the real world. \n\n\n\n\n\n\n\n\n\n\n\n\nCharles Tremblay\nAccount Manager at Leaseweb Canada\n\n\nCharles Tremblay is an Account Manager at Leaseweb Canada and has nearly 30 years of experience in the field of information technology. He has worked with numerous organizations in Canada and the United States operating in regulated environments\, with a particular focus on cybersecurity\, compliance\, and technology risk management. \n\n\n\n\n\n\n\n\n\n\n\n\nAndrée-Anne Chevalier\nPrésident of Vigilance Santé\n\n\nAndrée Anne Chevalier\, President of Vigilance Santé\, is a visionary leader who drives the advancement of health technologies with boldness\, rigor\, and ambition. For over 30 years\, Vigilance Santé has been developing clinical databases and decision-support software to promote excellence in medication therapy management. Her solutions help healthcare professionals across Canada optimize care and ensure patient safety. \nUnder her leadership\, Vigilance Santé continues to grow and accelerate innovation in the field of digital health. With an eye toward the future\, Andrée Anne Chevalier leverages technology and artificial intelligence to develop practical and responsible solutions that improve practices and the quality of care.
URL:https://www.biotech.ca/event/bioquebec-attaining-data-sovereignty-in-canada-a-practical-roadmap-for-life-sciences-using-quebec-private-cloud/
CATEGORIES:Member Event,Webinar
END:VEVENT
END:VCALENDAR